<?xml version="1.0" encoding="UTF-8"?>
<p id="p0095">The diverse intestinal microbiota shapes the immune system and promotes the host well-being [
 <xref rid="bb0200" ref-type="bibr">40</xref>,
 <xref rid="bb0205" ref-type="bibr">41</xref>]. The respiratory tract microbiota also influences the host immune responses to the virus [
 <xref rid="bb0210" ref-type="bibr">42</xref>]. While the immune responses to viral infection determine the efficacy of a vaccine, the disrupted gut microbiota contribute to vaccine failures and other inflammatory conditions [
 <xref rid="bb0215" ref-type="bibr">43</xref>]. The acute respiratory viral infections disrupt the host-microbiota interactions and create the intestinal dysbiosis with the post-viral immune responses, that contribute to pneumonia development by the secondary bacterial infection [
 <xref rid="bb0220" ref-type="bibr">44</xref>]. The healthy, diverse intestinal and respiratory tract microbiota is then another critical determinant for the clinical courses of COVID-19 [
 <xref rid="bb0210" ref-type="bibr">42</xref>,
 <xref rid="bb0225" ref-type="bibr">45</xref>].
</p>
